Erratum to: Effectiveness and Safety of CT-P13 (Biosimilar Infliximab) in Patients with Inflammatory Bowel Disease in Real Life at 6 Months

ERRATUM Erratum to: Effectiveness and Safety of CT-P13 (Biosimilar Infliximab) in Patients with Inflammatory Bowel Disease in Real Life at 6 Months F. Argu ¨elles-Arias 1 •M. F. Guerra Veloz 1 •R. Perea Amarillo 1 •A. Vilches-Arenas 1 • L. Castro Laria 1 •B. Maldonado Pe ´rez 1 •D. Chaaro 1 •A. Benı ´tez Rolda ´n 1 • V. Merino 2 •G. Ramı ´rez 2 •A. Caunedo A ´lvarez 1 •M. Romero Go ´mez 1,3 Published online: 28 June 2017 ÓSpringer Science+Business Media, LLC 2017 Erratum to: Dig Dis Sci (2017) 62:1305–1312 DOI 10.1007/s10620-017-4511-4 The article Effectiveness and Safety of CT-P13 (Biosimilar Infliximab) in Patients with Inflammatory Bowel Disease in Real Life at 6 Months, written by F. Argu ¨elles-Arias, M. F. Guerra Veloz, R. Perea Amarillo, A. Vilches-Arenas, L. Castro Laria, B. Maldonado Pe ´rez, D. Chaaro, A. Benı ´tez Rolda ´n, V. Merino, G. Ramı ´rez, A. Caunedo A ´lvarez and M. Romero Go ´mez, was originally published Online First without open access. After publication in volume 62, issue 5, page 1305–1312, the author decided to opt for Open Choice and to make the article an open access publication. Therefore, the copyright of the article has been changed to ÓThe Author(s) 2017 and the article is forthwith distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, a link is provided to the Creative Commons license and any changes made are indicated. The online version of the original article can be found under doi:10.1007/s10620-017-4511-4. &F. Argu ¨elles-Arias [email protected] M. F. Guerra Veloz [email protected] R. Perea Amarillo [email protected] A. Vilches-Arenas [email protected] L. Castro Laria [email protected] B. Maldonado Pe ´rez [email protected] D. Chaaro [email protected] A. Benı ´tez Rolda ´n [email protected] V. Merino [email protected] G. Ramı ´rez [email protected] A. Caunedo A ´lvarez [email protected] M. Romero Go ´mez [email protected] 1 UGC Digestivo Intercentros, Hospitales Universitarios Virgen Macarena-Rocı ´o (Sevilla), Avda Dr. Fedriani 3, 41007 Seville, Spain 2 Unidad de Farmacia, Hospital Universitario Virgen Macarena (Sevilla), Avda Dr. Fedriani 3, 41007 Seville, Spain 3 Direccio ´n Gerencia, Hospital Universitario Virgen Rocı ´o (Sevilla), Avda Manuel Siurot, s/n, 41013 Seville, Spain 123 Dig Dis Sci (2017) 62:2203 DOI 10.1007/s10620-017-4657-0